alanine has been researched along with clofazimine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au, WK; Cai, XH; Cao, J; Chan, CC; Chan, JF; Chanda, SK; Chen, H; Chu, H; Clausen, TM; Du, Y; Esko, JD; Hung, IF; Jin, DY; Kok, KH; Lai, PM; Lau, CY; Lee, AC; Li, RA; Liang, R; Matsunaga, N; Meng, X; Oh, J; Pache, L; Pihl, J; Poon, VK; Pu, Y; Riva, L; Sheng, L; Sit, KY; Sun, H; Sun, R; Sze, KH; Tang, K; Tang, YD; Wang, D; Wang, R; Xu, W; Ye, ZW; Yin, X; Yuan, S; Yuen, CK; Yuen, KY; Zhang, AJ; Zhang, YY | 1 |
1 other study(ies) available for alanine and clofazimine
| Article | Year |
|---|---|
Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Antiviral Agents; Biological Availability; Cell Fusion; Cell Line; Clofazimine; Coronavirus; Cricetinae; DNA Helicases; Drug Synergism; Female; Humans; Life Cycle Stages; Male; Mesocricetus; Pre-Exposure Prophylaxis; SARS-CoV-2; Species Specificity; Spike Glycoprotein, Coronavirus; Transcription, Genetic | 2021 |